Rituximab for membranous nephropathy and immune disease: less might be enough.
Ruggenenti
Piero
P
Renal Medicine Department, Mario Negri Institute for Pharmacological Research, Bergamo, Italy.
Cravedi
Paolo
P
Remuzzi
Giuseppe
G
D000911:Antibodies, Monoclonal / Q000008:administration & dosage*; D058846:Antibodies, Monoclonal, Murine-Derived; D015433:Glomerulonephritis, Membranous / Q000188:drug therapy* / Q000276:immunology*; D006801:Humans; D007154:Immune System Diseases / Q000188:drug therapy; D007155:Immunologic Factors / Q000008:administration & dosage*; D000069283:Rituximab
D000911:Antibodies, Monoclonal; D058846:Antibodies, Monoclonal, Murine-Derived; D007155:Immunologic Factors; D000069283:Rituximab